UNITED STATES

                         SECURITIES AND EXCHANGE COMMISSION

                               Washington, D.C. 20549

                                      FORM 10Q

                [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
                       OF THE SECURITIES EXCHANGE ACT OF 1934

                    For the quarterly period ended July 31, 1997

                                         OR

                   [ ] TRANSITION REPORT PURSUANT TO SECTION 13 or
                    15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

              or the transition period from ___________ to ____________

                           Commission File Number 0-11718


                                   Stevia Company, Inc.
                                  _____________________

               (Exact name of registrant as specified in its charter)


              Illinois                                    36-2967419 
             _______________________________         ____________________
              (State or other jurisdiction of         (I.R.S. Employer
              incorporation or organization)          Identification No.)


             1940 East Devon Avenue, Elk Grove Village,  Illinois     60007
             ______________________________________________________________
             (Address of principal executive offices)            (Zip Code)

          Registrant's telephone number, including area code: (847) 593-0226 

          Indicate by check mark whether the registrant (1) has filed all
          reports required to be filed by Section 13 or 15(d) of the
          Securities Exchange Act of 1934 during the preceding 12 months
          (or for such  shorter period that the registrant  was required to
          file such reports), and (2) has been subject to such filing
          requirements for the past 90 days.

          Yes   X   No  
              _____    _____

          Number of shares outstanding of common stock as of the close of
          the period covered by this report:  32,195,300

          Page 1 of 22 pages contained in the sequential numbering system.

<PAGE>
                           PART 1 - FINANCIAL INFORMATION



          Item 1.   FINANCIAL STATEMENTS




          Board of Directors and Shareholders
          Stevia Company, Inc.
          Elk Grove Village, Illinois






               The accompanying balance sheet of STEVIA COMPANY, INC. at
          July 31, 1997 and the related statements of operations,
          shareholders'  equity and cash  flow for the  three month periods
          ended  July 31,  1997 and  1996  were not  audited; however,  the
          financial statements for the three months periods ending July 31,
          1997 and 1996 reflect all adjustments (consisting  only of normal
          reoccurring adjustments) which are, in the opinion of management,
          necessary  to   provide  a  fair  statement  of  the  results  of
          operations for the interim period presented.

               The  financial statements for the year  ended April 30, 1997
          were not audited pursuant to Rule 210.3-11 promulgated under
          Securities and Exchange Act of 1934; however, the financial
          statements for the fiscal year ending April 30, 1997 reflect all
          adjustments (consisting only of normal reoccurring adjustments)
          which are, in the opinion of management, necessary to provide a
          fair statement of the results of operations for the fiscal year
          presented.






          STEVIA COMPANY, INC.
          September 16, 1997

<PAGE>
<TABLE>
                                 STEVIA COMPANY, INC.
                                    BALANCE SHEET
                                        ASSETS

<CAPTION>
                                            July  31,  1997   April  30, 1997
                                                 Unaudited      Unaudited   
                                               _____________  _____________
<S>                                            <C>            <C>
  CURRENT ASSETS
    Cash                                              821          6,574

    Accounts Receivables-other                      9,048          9,668
    Inventories                                    25,323         25,323
    Prepaid Expenses                                  422              5
                                               _____________  ______________
           Total Current Assets                    35,614         41,570  

  PROPERTY AND EQUIPMENT (Notes 1 and 3)
    Land                                             1,127          1,127
    Furniture and Equipment                         44,750         44,750
    Building                                       483,200        483,200
    Idle Equipment                                 121,728        121,728
                                               _____________  ______________
                                                   650,805        650,805
    Less:  Accumulated Depreciation               (102,737)       (98,902)
                                               _____________  ______________
                                                   548,068        551,903  
                                               _____________  ______________
  OTHER ASSETS
   Patents, Net of Amortization                    12,725         13,115
   Investment in Affiliated Company
     (Note 5)                                         -               -     
                                                ____________  ______________
                                                 596,407         606,588   
                                                ____________  ______________
                                                ------------  --------------
</TABLE>
<TABLE>
     
                         LIABILITIES AND SHAREHOLDERS' EQUITY
<S>                                              <C>           <C>
     CURRENT LIABILITIES
       Accounts Payable                                33,139         43,849
       Notes Payable-Officer
        (Notes 4 and 6)                                 2,588          7,588
       Due to Affiliates (Note 4)                     358,991        349,286
       Accrued Executive Compensation                 124,524        124,524 
       Deferred Rent                                      310            309
       Accrued Expenses                                 9,539          6,597
                                                  ___________  ______________
               Total Current Liabilities              529,091        532,153
                                                  ___________  ______________
                                                  -----------  --------------
     NON-CURRENT LIABILITIES
       Tenant Security Deposit                          3,245          3,245
                                                  ___________  ______________

     COMMITMENTS AND CONTINGENCIES
       (Notes 5,  9 and 10)                                -             - 
                                                  ___________  ______________

     SHAREHOLDERS' EQUITY (Notes 4 and 7)
       Common Stock, No Par Value, 100,000,000
        Shares Authorized as of April 30, 1997
        and July 31, 1997; Issued 32,195,300
        Shares at April 30, 1997 and July 31, 1997   2,088,001     2,088,001
       Additional Paid in Capital                          100           100
       Accumulated Deficit                          (2,024,030)   (2,016,911)
                                                  ____________  ______________
                                                       64,071         71,190 
                                                  _____________  _____________
                                                       596,407       606,588 
                                                  ____________  ______________
                                                  ------------  --------------
<FN>
    The accompanying notes are an integral part of the financial statements.
<PAGE>

</TABLE>
<TABLE>

                                 STEVIA COMPANY, INC.
                               STATEMENT OF OPERATIONS
                                      Unaudited

<CAPTION>

       
                                             Three Months Ended July 31,    
                                             ___________________________
                                                  1997           1996  
                                             ____________    ______________
<S>                                          <C>             <C>
     REVENUES
       Sales                                        -              - 

     COST OF SALES                                  -              -        
                                             ____________    ______________
     Gross Profit (Loss)                            -              - 

     OPERATING EXPENSES
       Marketing                                    -                28
       Research and Development                     390             390  
       General and Administrative                13,178          13,350
                                             ____________    _____________
                                                 13,568          13,768  
                                             ____________    _____________
     Loss From Operations                       (13,568)        (13,768) 
                                             ____________    ______________
     
     OTHER INCOME AND (EXPENSE)
       Rental Income                              6,449           5,954     
                                             _____________   ______________
                                                  6,449           5,954     
     NET LOSS                                    (7,119)        ( 7,814)  
                                             _____________   ______________
                                             -------------   --------------
     NET LOSS PER COMMON SHARE
         (Note 8)                                 (.001)          (.001)    
                                             _____________   ______________
                        
     WEIGHTED AVERAGE COMMON
     SHARES OUTSTANDING                      32,195,300      32,195,300  
                                            _____________   ______________
                                            -------------   --------------





<FN>
     The accompanying notes are an integral part of the financial statements.
</TABLE>
<PAGE>
<TABLE>

                                   STEVIA COMPANY, INC.

                             STATEMENT OF SHAREHOLDERS' EQUITY

                             THREE MONTHS ENDED JULY 31, 1997

                                         Unaudited
<CAPTION>
                                                                      Total
                                                 Additional           Share-
                           Common Stock          Paid-in             holders'
                       Shares        Amount     Capital    (Deficit)  Equity
                       __________  __________   _________  ___________ ________
<S>                   <C>          <C>          <C>        <C>         <C>
   BALANCE
     May 1, 1997      32,195,300   2,088,001     100       (2,016,911) 71,190

   NET INCOME (LOSS)       -            -         -        (    7,119) (7,119)
                      ___________  ___________  _________  ____________ ______

   BALANCE,
     July 31, 1997    32,195,300   2,088,001     100      (2,024,030)  64,071
                      ___________  __________   _________  ___________ ________
                      -----------  ----------  ---------- ------------ --------


<FN>
     The accompanying notes are an integral part of the financial statements
</TABLE>
<PAGE>
<TABLE>

                                   STEVIA COMPANY, INC.

                                 STATEMENT OF CASH FLOW

                                      Unaudited


<CAPTION>
                                                Three Months Ended July 31,
                                                 _________________________
                                                 1997             1996   
                                                 _________________________
<S>                                              <C>           <C>

OPERATING ACTIVITIES:   
  Net Loss                                       ( 7,119)       (  7,814)
  Adjustments to Reconcile Net (Loss) to Net
   Cash Used by Operating Activities:
  Depreciation and Amortization                    4,225           4,225
  Changes in Operating Assets and Liabilities:
  (Increase) Decrease in Receivables                 620             -
  (Increase) Decrease in Inventories
   repaid Expenses                             (     417)        (   449)
  Increase (Decrease) in Accounts Payable and
    Accrued Expenses                             ( 7,767)          3,850
  Increase (Decrease) in Due to Affiliates
    (Note 4)                                       9,705           4,707    
                                                 _____________  ___________
  Net Cash Provided (Used) by Operating
    Activities                                  (    753)          4,519    
                                                 _____________  ___________

  INVESTING ACTIVITIES:
    (Increased) Decrease in Furniture
       and Equipment                                  -          (    15)  
                                                 -------------  -----------
  Net Cash Provided (Used) by    
    Investing Activities                              -          (    15)  
                                                 -------------  -----------
  FINANCING ACTIVITIES:
  Proceeds From (Repayments of) Notes (Note 6)    (  5,000)           -     
                                                  _____________  ___________
  Net Cash Provided (Used) by Financing
    Activities                                    (  5,000)           -     
                                                  _____________  ___________

  Increase (Decrease) in Cash and
  Cash Equivalents                                (  5,753)         4,504
  Cash and Cash Equivalents at
  Beginning  of Period                               6,574          1,431 
  Cash  and Cash Equivalents at End  of Period         821          5,935   
                                                  -------------- -----------
<FN>     
     The accompanying notes are an integral part of the financial statements.

</TABLE>
<PAGE>

                            STEVIA COMPANY, INC.

                       NOTES TO FINANCIAL STATEMENTS



     1.   Summary of Significant Accounting Policies:

          Inventories - Harvested crop inventories are stated at the
          lower of cost (determined by actual specific production
          cost) or market value (less estimated cost of disposal).

          Components of inventories are as follows:

                                        July 31, 1997  April 30, 1997       
                                        _____________  ______________

                         Seeds             18,361           18,361
                         Leaves             6,962            6,962
                                        _____________  ______________
                                        $  25,323      $    25,323  
                                        _____________  ______________
                                        -------------  --------------

          Research and Development, and Patents - Research and
          development expenditures, including depreciation of
          laboratory equipment, are charged to operations as incurred.
          The costs of obtaining patents, primarily legal fees, are
          capitalized and amortized over seventeen years on the
          straight-line method.

          Property and Equipment - Property and equipment are stated
          at cost.  Depreciation and amortization are computed,
          primarily on the straight-line and accelerated methods, over
          the estimated useful lives of the respective assets.
          Repairs and maintenance are charged to expenses as incurred;
          renewals and betterments which significantly extend the
          useful lives of existing property and equipment are
          capitalized.

     2.   Company Organization and Description:

          Stevia Company, Inc. was incorporated under the laws of the
          State of Illinois on November 22, 1976.

          The Company was organized primarily to engage in the
          business of developing and manufacturing natural products,
          including sweeteners, derived from the Stevia rebaudiana
          plant.

     3.   Property and Equipment:

          In 1986, the Company completed construction of a building
          for a sweetener production facility in Pueblo, Colorado on a
          parcel of land (25 acres) acquired by the Company.  The net
          price for construction of the building was $483,200.  The
          Company also purchased certain equipment for its processing
          facility.  Completion of the processing facility was
          terminated in 1987 due to lack of funds.  See Footnote 11.

          On September 1, 1993, the Company entered into a three-year
          lease for its Pueblo, Colorado facility with an unaffiliated
          third party.  The tenant was granted two one-year options
          and a first right of refusal to purchase the Pueblo,
          Colorado facility in the event the Company sells or
          otherwise disposes of the facility.  The lease provides for
          base rent of $19,473 for the first two years, $20,466 for
          the third year, $22,394 for the first option year and
          $23,264 for the second option year. 

     4.   Related Party Transactions:

          The Company was indebted to affiliated companies as follows:

                                             July 31,       April 30,
                                               1997           1997  
                                             _________      _________
          F.K. Suzuki International, Inc.    $  70,412      $  70,412
          Biosynergy, Inc.                   $ 288,579      $ 278,874
                                             _________      _________
                    Totals                   $ 358,991      $ 349,286
                                             _________      _________
                                             ---------      ---------
     
          The amount due to F.K. Suzuki International, Inc. is the net
          license fees due under an irrevocable exclusive license
          agreement with F.K. Suzuki International, Inc. described in
          Note 9, less certain prepayments and discounts with regard
          to such license agreement.

          The Company shares common offices with Biosynergy, Inc.
          Each company has incurred certain shared office expenses
          which have been allocated to the other company.  The Company
          a net payable of $288,579 at July 31, 1997 as compared to a net
          payable of $278,874 at April 30, 1997.

          The Company and its affiliates are related through Common
          Stock ownership as follows on July 31, 1997.

<PAGE>
                           STEVIA COMPANY, INC.

                       NOTES TO FINANCIAL STATEMENTS


     4.   (Continued)
<TABLE>
<CAPTION>
                    
                                   S T O C K   O F   A F F I L I A T E S    
                          ___________________________________________________
                                                        F.K. Suzuki
                               Stevia   Biosynergy     International  Medlab
     Stock Owner               Company      Inc.            Inc.       Inc.
     ___________               ________ __________     _____________  ______
   <S>                         <C>       <C>           <C>            <C>

     Stevia Company, Inc.        -         13.8%             -           -
     Biosynergy, Inc.            .4%         -               -           -
     F.K. Suzuki
      International, Inc.      55.8%       18.8%             -         100.0%
     Medlab, Inc.                -           -               -            -
     Fred K. Suzuki, Officer/    -           -             35.6%          -
      Director
     Lauane C. Addis, Officer/   .1%         .1%           32.7%          -
      Director
     James F. Schembri,          .2%       12.9%             -            -
      Director
</TABLE>

          On July 7, 1983, Biosynergy, Inc. (an affiliated company)
          successfully completed a public offering.  As part of this
          public offering the Company exchanged 1,058,181 shares of
          its Common Stock for 2,000,000 shares of Biosynergy, Inc.'s
          Common Stock.  The Common Stock of the Company had no book
          value at the time of the exchange; thus no dollar value was
          assigned to the transaction.  The Company sold 100,000
          of these shares.  Although Biosynergy, Inc.'s Common Stock
          can be traded in the over-the-counter market, there is no
          established public trading market for such Common Stock due
          to limited and sporadic trades.

          In June, 1993, Fred K. Suzuki, President of the Company,
          advance including legal fees, of settling a lawsuit.  The Company
          shares offices in Elk  Grove Village, Illinois with  Biosynergy,
          Inc.   The master lease for  these offices,  which  expires January
          31, 2001,  is in  the name  of Biosynergy,  Inc.   The total annual
          base  rent  for these  premises is $60,500.00 for 1 year,
          $68,199.96 for years 2 and 3,  and  $69,300.00  for  years 4 and 5.
          The Company's portion is $9,075.00 for year 1, $10,230.00 for years
          2 and 3, and  $10,395.00 for years 4 and 5.

     6.   Notes Payable:  

          Notes Payable - Officer consists of the following:

          .    an unsecured note dated July 1, 1993 in the original
               amount of $7,588 payable to Fred K. Suzuki, President.
               The note is due on demand and bears interest at 10% per
               annum.  The principal balance due at July 31, 1997 is
               $2,588.

     7.   Shareholders' Equity:

          The authorized capital stock of Stevia Company is one
          hundred million (100,000,000) shares of no par value Common
          Stock and one hundred thousand (100,000) shares of $100 par
          value Preferred Stock.  The preferences, qualifications,
          limitations, restrictions and special or relative rights in
          respect to the Preferred Stock are to be determined by the
          Board of Directors at the time of their issuance, subject to
          limitations set forth in the amended articles of
          incorporation.  As of April 30, 1997 and July 31, 1997, no
          shares of Preferred Stock were outstanding.

          On November 1, 1989, the Company's Secretary, Lauane C.
          Addis, and President, Fred K. Suzuki, agreed to forego their
          salaries in exchange for an option to purchase 83,333 shares
          of the Company's no par value common stock for each month
          they forfeited their salary at an option price of $.025 per
          share.  Accrual of these options was terminated effective


<PAGE>

                           STEVIA COMPANY, INC.

                       NOTES TO FINANCIAL STATEMENTS

     7.   (Continued)

          April 30, 1991.  These options may be exercised until one
          year after the respe due at October 31, 1989, the optionee's salary
          is reinstated, or the optionee is no longer employed by the
          Company, whichever is later.  As of July 31, 1997, none of
          these options have been exercised and a total of 2,999,988
          shares are subject to the options.  These options provide
          for adjustments to prevent dilution in the event of capital
          reorganizations.

          Mr. Suzuki was granted an option to convert all or a portion
          of his deferred compensation into shares of the Company's no
          par value common stock at a conversion rate of $.025 of
          deferred compensation per share.  Conversion can only occur
          in the event the Company has sufficient liquid assets to pay
          all employee taxes due upon issuance of the shares.  A total
          of 1,448,917 shares have been reserved for Mr. Suzuki's
          option.  No portion of the option has been exercised as of
          July 31, 1997.  The option provides for adjustments to
          prevent dilution in the event of capital reorganizations.

     8.   Income (Loss) per share:

          Net income (loss) per share is computed based on the
          weighted average number of shares of Common Stock
          outstanding during the period, after giving effect to stock
          splits.  The effect of exercise of stock options has not
          been presented as exercise would be anti-dilutive.

     9.  Agreements, Licenses and Options:

          The Company entered into an irrevocable exclusive license
          agreement with F.K. Suzuki International, Inc., parent of
          the Company, in 1983.  For an annual fee of $75,000, payable
          beginning in January of 1987, the Company received certain
          patent and other rights owned by F.K. Suzuki International,
          Inc.  Effective May 1, 1988, the license agreement was
          amended to provide for a royalty payment of 3% of revenues
          derived from the licensed technology in lieu of a set fee.
          There was no fee incurred during the three month period
          ending July 31, 1997.


<PAGE>

                          STEVIA COMPANY, INC.

                       NOTES TO FINANCIAL STATEMENTS                  


     10.  Income Taxes:

          There is no provision for income taxes in the accompanying
          financial statements due to the Company's net operating loss
          position.  At April 30, 1997, net operating loss
          carryforwards are available and expire, if not used, as
          follows:

                                   1996               51,092
                                   1997              292,440
                                   1998              224,075
                                   1999              167,356
                                   2000              302,320
                                   2001              423,843
                                   2002              389,355
                                   2003              328,154
                                   2004              189,389
                                   2005              133,704
                                   2006               74,264
                                   2007               73,470
                                   2008               49,568
                                   2009              119,410
                                   2010               55,831
                                   2011               33,519
                                   2012               37,407
                                                  __________
                                                  $3,064,297
                                                  __________
                                                  ----------

       The Company has adopted Statement of Financial Accounting
       Standards (SFAS) No. 109, "Accounting for Income Taxes"
       Due  to the  historical  and  continued net  operating  losses of  the
       Company,  Statement  109  has  no  material effect,  if  any,  on  the
       Company's  Financial Statements.    The  Company  has elected  not  to
       retroactively  adopt the provisions  allowed in SFAS  NO.109; however,
       all provisions of  the document have been applied  since the beginning
       of fiscal year 1994.  

     11.  Management's Plans:

          In view of the fact that the Company has incurred losses of
          $37,407, $33,519 and $55,831 for the years ended April 30,
          1997, 1996, and 1995, respectively, management of the
          Company recognizes the ability of the Company to continue is
          contingent upon the Company obtaining financing so it can commence
          operations or acquire alternative operations. Before the Company
          can realize material operating revenues from its proposed
          operations, the Company must equip and commence operations
          of a processing facility.  The cost of equipping a processing
          facility is significant, and therefore the Company's main
          objective has been to obtain such financing.  Although the Company
          will continue to seek financing for its proposed operations, the
          Company will also pursue alternatives, such as licensing its
          technology, selling Stevia Company or its assets, or combining Stevia 

                                          14

<PAGE>

        Company with another enterprise.  Although no agreements have been
        entered into for consummating any such transaction, management of
        the Company believes such a transaction may be possible in the future.

     12.  Unaudited Financial Statements:

          The Company's Financial Statements for the fiscal year
          ending April 30, 1997 were not audited pursuant to Rule
          210.3-11 of Regulation SX promulgated under the Securities
          Exchange Act of 1934, which provides that an inactive entity
          need not submit audited financial statements with reports
          filed pursuant to the Securities Exchange Act of 1934.  An
          inactive entity is defined as an entity not having gross
          receipts from all sources and expenditures for all purposes
          in excess of $100,000 each, which has not purchased or sold
          any of its own stock, granted options therefore, or levied
          any assessments against outstanding stock during the
          applicable fiscal year, which has had no material change in
          business, including any material acquisitions or
          dispositions of assets, and which is not required to publish
          audited financial statements by any exchange or governmental
          authority having jurisdiction.  In the opinion of
          Management, the Company met the criteria of an inactive
          entity for the fiscal year ending April 30, 1997.

                                    15

<PAGE>

  Item 2.   MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND 
            _______________________________________________________________
            RESULTS OF OPERATIONS 
            _____________________

     SALES/REVENUES
     ______________

       The Company had no sales during the quarter ending July 31, 1997 ("1st
  Quarter").  The Company did not produce rebaudioside A or other products on
  a commercial basis during the 1st Quarter, and was not expected to have
  sales.  After commencement of commercial operations, Management continues
  to believe that a market for its Stevia products could be developed.

      During the quarter ending July 31, 1997, the Company realized rental
  income of $6,449 from leasing its Pueblo, Colorado facility as a result of
  a tenant first right of refusal upon the sale of other disposition of the
  Pueblo facility and  provides for two one-year options.  The first one-year
  option  term  expires August  31, 1997.    The lease  provides for  rent of
  $22,394 for the first option year and $23,264 for the second option year.

  COSTS AND EXPENSES
  __________________

      The overall operating expenses of the Company decreased by $200 during
 the 1st Quarter as compared to the same quarter ending in 1996.  Most of
 the current expenses are overhead and general and administration items
 required to maintain the Company.  It is not anticipated that the expenses
 of the Company will materially change until the Company receives financing
 or commences alternative operations.

 NET LOSS
 ________

      The Company realized a net loss of $7,119 in the 1st Quarter as
 compared to a net loss of $7,814 in the comparative quarter in 1996.  The
 Company's continuing losses are due to the lack of operating revenues,
 which will continue until such time as the Company produces its sweeteners
 and other products for sale or can obtain alternative revenues.  See
 "LIQUIDITY AND CAPITAL RESOURCES" below.

     As of April 30, 1997, the Company has incurred net operating losses
 aggregating $3,064,297.  There is no provision for income taxes in the
 Financial Statements due to the Company's net operating loss position.
 Furthermore, the Tax Reform Act of 1986 will not materially alter the
 Company's net operating loss carryforward position, and the net operating
 loss carryforwards will be available and expire, if not used, as set forth
 in Footnote 10 to the Financial Statements for the 1st Quarter.  See
 "FINANCIAL STATEMENTS."

 ASSETS/LIABILITY RATIO
 ______________________

     The ratio of current assets to current liabilities (.07 to 1) is not
 acceptable taking into consideration the Company's cash flow position.  The
 Company's current assets consist primarily of inventory.  It is unknown how
 much inventory the Company can sell, if any.  The Company is not producing
 inventory and there can be no assurance of long-term revenues, if any.  The
 inventory consists primarily of Stevia leaves, which have been grown and
 harvested by the Company for use in its initial processing operations or
 for sale, and seeds which can be used for growing more leaves.  See
 "LIQUIDITY AND CAPITAL RESOURCES" below.


                                          16


<PAGE>

  LIQUIDITY AND CAPITAL RESOURCES

      The Company's net working capital decreased by $2,894 during the 1st
 Quarter.  The Company's negative net working capital is due to the
 continuing losses of the Company.  The Company had  $821 in cash and $9,048
 in receivables at July 31, 1997.  Management of the Company believes this
 amount is insufficient to provide working capital for the ensuing quarter.
 The Company does not have, nor does it anticipate obtaining in the near
 future, a working line of credit.

      The Company's ability to generate cash adequate to meet its future
 needs depends upon its ability to obtain financing for the purpose of
 beginning revenue producing operations.  In the event the Company is unable
 to obtain financing, management will seek out alternatives, such as
 licensing the Company's technology, selling the Company or its assets,
 leasing the Company's Pueblo facility, or combining the Company with other
 businesses.

     The Company and an affiliate, Biosynergy, Inc. ("BSI"), share office
 space, and as a result, share certain expenses.  Both companies account to
 each other on an on-going basis for these shared expenses.  The resulting
 payable as of April 30, 1997 was $278,874 and $288,579 as of July 31, 1997.

     The amounts due to BSI reflect on-going transactions in the ordinary course
 of business  and do not  represent any extraordinary transactions.   Expense
 salary for common employees and related benefits, payroll overhead,
 utilities,  and  certain  legal expenses.    Management  of  the Company
 more economical to share these expenses with BSI, and will likely continue
 to do so in the near future.  However, there is no assurance BSI will be in
 a position or agree to continue to extend credit to the Company for these
 shared expenses.

     On September 1, 1993, the Company entered into a three-year lease for
 its Pueblo, Colorado facility with an unaffiliated third party.  The tenant
 was granted two one-year options and a first right of refusal to purchase
 the Pueblo, Colorado facility in the event the Company sells or otherwise
 disposes of the facility.  The lease provides for base rent of $19,473 for
 the first two years, $20,466 for the third year, $22,394 for the first
 option year and $23,264 for the second option year.  See "SALES/REVENUES"
 above.  The proceeds from leasing such facility are used to offset expenses
 of the facility and to cover a portion of the general and administrative
 expenses of the Company.  However, the cash flow from leasing the facility
 in Pueblo is not expected to be sufficient to cover all of the expenses of
 the Company for the ensuing year, and furthermore, there can be no
 assurance the Company  will be able to  continue leasing its facility.   In
 this regard,  the lesee of the facility has  exercised its option to extend
 the lease  for the final option year.  However, the lessee is in default in
 the payment of rent and other charges  under the lease, and there can be no
 assurance such defaults will be cured and the lease continued.

     The Company owns 1,900,000 shares of BSI common stock.  Such common
 stock can be traded in the over-the-counter market and stock prices are
 recorded on "pink sheets."  The bid price at July 31, 1997 was estimated to
 be $.01 per share.  Although the Company is free to currently sell these
 shares of Biosynergy, Inc. common stock, it does not have plans to do so in
 the near future.  See Footnote 4 of the "FINANCIAL STATEMENTS."

                                     17

<PAGE>

                            PART II - OTHER INFORMATION  
                            ___________________________

     Item 6.   EXHIBITS AND REPORTS ON FORM 8-K.
               _________________________________

     A.   The following Exhibits are included herein pursuant to Section 601:

          (3)  

               (a)  Articles of Incorporation (i)
         
               (b)  By-Laws (ii)

          (10) Material Contracts.

               (a)  Lease Agreement, dated September 1, 1993, between the
                    Company and Pacific Aero Manufacturing, Inc. (iii)

               (b)  Promissory Note dated July 1, 1993 payable to Fred K. Suzuki
                    in the amount of $7,587.75. (iii)

          (11) Statement regarding computation of per share earnings - none.

          (15) Letter dated September 16, 1997, regarding interim financial
               information. (iv)

          (18) Letter regarding change in accounting principals - none.

          (19) Reports furnished to security holders - none.

          (22) Published  report regarding matters submitted to vote of security
     holders - none.

          (23) Consents of experts and counsel - none.

          (24) Power of Attorney - none.

          (27) Financial Data Schedule. P. E-1

     B.   No Current Reports on Form 8K were filed during the period covered by
          this Report.

    _________________________
    [FN]
           (i)  Incorporated by reference to a Registration Statement filed
                on Form S-18 with the Securities and Exchange Commission,
                1933 Act, Registration Number 2-87364C, under the Securities
                Act of 1933, as amended, and incorporated by reference, to
                the extent of Articles of Amendment, to Form 10K for Fiscal
                Year Ending April 30, 1986 filed with the Securities and
                Exchange Commission.

           (ii) Incorporated by reference to Form 10K for Fiscal Year Ending
                April 30, 1987 filed with the Securities and Exchange
                Commission.

           (iii) Incorporated by reference to Form 10K for Fiscal Year ending
                 April  30, 1994  filed  with  the  Securities  and  Exchange
                 Commission.

                                          18

<PAGE>

           (iv) This Exhibit is included in this report as a part of
                the Financial Statements, and is incorporated by
                reference herein.

                                      19
<PAGE>


                                 SIGNATURES


          Pursuant to the requirements of the Securities Exchange Act of 1934,
     the registrant has duly caused this report to be signed on its behalf by
     the undersigned thereunto duly authorized.

     STEVIA COMPANY, INC.

     Date September 18,1997                 /s/ FRED K. SUZUKI /s/             
                                             ---------------------------------
                                             Fred K. Suzuki
                                             President, Chairman of  the Board,
                                             Chief Accounting Officer and      
                                             Treasurer

     Date September 18,1997                 /s/ LAUANE C. ADDIS /s/            
                                             --------------------------------
                                             Lauane C. Addis
                                             Secretary, Corporate Counsel and
                                             Director


     <PAGE>




























  ___________________________________________________________________________




                                          20


<PAGE>

                         SECURITIES AND EXCHANGE COMMISSION
                               WASHINGTON, D.C. 20549



                                      FORM 10Q

                  Quarterly Report Pursuant to Section 13 or 15 (d)

                                        of

                      THE SECURITIES AND EXCHANGE ACT OF 1934

                        For the period ending July 31, 1997
                         Commission File Number: 0-11718


                                STEVIA COMPANY, INC.              
           _________________________________________________________________
                 (Exact name of registrant as specified in charter)

                              1940 East Devon Avenue
                          Elk Grove Village, IL 60007
                                 (847) 956-0471
               (Address and telephone number of registrant's  principal        
       
                    executive office on a principal place of business)

                       __________________________________





     <PAGE>
                                    EXHIBITS


     ___________________________________________________________________________

     ___________________________________________________________________________

<PAGE>

                                  EXHIBIT INDEX 
                                  _____________
                                                                 Page Number
                                                                 Pursuant to
                                                                 Sequential
          Exhibit                                                Numbering
          Number         Exhibit                                 System  
          ___________    _______                                 __________

          27             Financial Data Schedule                   E-1

  <PAGE>